15 Sep

Latest Product Launch Expands BD’s Genomics Portfolio

WRITTEN BY Sarah Collins


Becton, Dickinson and Company (BDX), or BD, accelerated its strategy to establish itself as the leader in single cell genomics with its recent launch of BD Rhapsody, a single cell analysis platform, on September 12, 2017. The platform will be used for gene expression profiling. It has the ability to “detect rare molecules responsible for biological diversity that are often missed with whole transcriptome profiling.”

Latest Product Launch Expands BD’s Genomics Portfolio

The platform was developed using UMI (unique molecular index) technology, which is a patent technology of BD, acquired through the acquisition of Cellular Research in 2015. BD Rhapsody is a complete system for single cell analysis that consists of instruments, reagents, and software. The platform was installed under limited commercial release earlier with the name of Resolve.

Investors can gain diversified exposure to BD by investing in the iShares Russell 1000 Growth ETF (IWF). IWF holds approximately 0.37% of its total holdings in BD.

Features and capabilities

The company is planning to expand BD Rhapsody rapidly over the next one year and includes protein analysis in addition to RNA analysis. The company will leverage its extensive antibody portfolio with BD AbSeq assays. The device will be offered with application-specific targeted panels as well as custom targeted panels.

According to Stephen Gunstream, vice president of genomics at BD, “Early access users have been enthusiastic about our targeted assay solution and its superior performance compared to whole transcriptome profiling. These same users have also experienced considerable sequencing cost savings from this technology.”

The device is expected to be commercially available in 1H18. BD has an opportunity to gain market share in this market from other big players like Thermo Fisher Scientific (TMO), Boston Scientific (BSX), and Illumina (ILMN).

Latest articles

With over 38,000 restaurants, McDonald's doesn’t make any of its products. Instead, it contracts with suppliers to meet its massive requirements.

In Q3, T-Mobile’s (TMUS) strong momentum continued. The telecom giant gained postpaid phone customers and reported strong earnings.

Energy Transfer stock (ET) has been under pressure due to a weak earnings season from MLPs, but its fundamentals are stronger than ever.

Former HBO CEO Richard Plepler is in "advanced talks" over a deal with Apple TV+ (AAPL), the Wall Street Journal reported on Tuesday.

At 11:46 AM ET, US crude oil prices were up 0.7% from the last trading session. The EIA plans to release its inventory report tomorrow.

Footwear and apparel giant Nike (NKE) has decided to stop selling its products on Amazon (AMZN), ending a program that's run since 2017.